SE309648B - - Google Patents

Info

Publication number
SE309648B
SE309648B SE4970/59A SE497059A SE309648B SE 309648 B SE309648 B SE 309648B SE 4970/59 A SE4970/59 A SE 4970/59A SE 497059 A SE497059 A SE 497059A SE 309648 B SE309648 B SE 309648B
Authority
SE
Sweden
Application number
SE4970/59A
Inventor
K Bergstroem
J Sjoevall
Original Assignee
K Bergstroem
J Sjoevall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by K Bergstroem, J Sjoevall filed Critical K Bergstroem
Publication of SE309648B publication Critical patent/SE309648B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P31/00—Preparation of compounds containing a five-membered ring having two side-chains in ortho position to each other, and having at least one oxygen atom directly bound to the ring in ortho position to one of the side-chains, one side-chain containing, not directly bound to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having at least one oxygen atom bound in gamma-position to the ring, e.g. prostaglandins
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/42—Platinum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
SE4970/59A 1958-05-28 1959-05-25 SE309648B (xx)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US738514A US3069322A (en) 1958-05-28 1958-05-28 Pge and pgf
GB12139/62A GB1040544A (en) 1958-05-28 1962-03-29 Improvements in or relating to therapeutic compounds and the manufacture thereof
US20375262A 1962-06-20 1962-06-20
US11511071A 1971-02-12 1971-02-12
US11511371A 1971-02-12 1971-02-12
US28304572A 1972-08-23 1972-08-23
US00282952A US3852337A (en) 1958-05-28 1972-08-23 Pgf tetraols and alkanoyl esters

Publications (1)

Publication Number Publication Date
SE309648B true SE309648B (xx) 1969-03-31

Family

ID=27562618

Family Applications (7)

Application Number Title Priority Date Filing Date
SE4970/59A SE309648B (xx) 1958-05-28 1959-05-25
SE3301/63A SE323473B (xx) 1958-05-28 1963-03-26
SE14920/64A SE305870B (xx) 1958-05-28 1964-12-10
SE14917/64A SE339531B (xx) 1958-05-28 1964-12-10
SE14918/64A SE305868B (xx) 1958-05-28 1964-12-10
SE14919/64A SE305869B (xx) 1958-05-28 1964-12-10
SE15331/66A SE337887B (xx) 1958-05-28 1966-11-09

Family Applications After (6)

Application Number Title Priority Date Filing Date
SE3301/63A SE323473B (xx) 1958-05-28 1963-03-26
SE14920/64A SE305870B (xx) 1958-05-28 1964-12-10
SE14917/64A SE339531B (xx) 1958-05-28 1964-12-10
SE14918/64A SE305868B (xx) 1958-05-28 1964-12-10
SE14919/64A SE305869B (xx) 1958-05-28 1964-12-10
SE15331/66A SE337887B (xx) 1958-05-28 1966-11-09

Country Status (5)

Country Link
US (6) US3069322A (xx)
DE (4) DE1160981B (xx)
DK (2) DK126106B (xx)
GB (3) GB851827A (xx)
SE (7) SE309648B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003441A1 (en) * 1984-02-13 1985-08-15 Lars Hellgren An erection and fertility promoting agent, a method for producing the same, and the use thereof in the production of erection and fertility promoting compositions

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643739B1 (de) * 1958-05-28 1972-06-29 Sune Bergstroem Epi-PGF,Bisdehydro-epi-PGF,Tetradehydro-epi-PGF,deren Methylester und Methylestertriacetate und Verfahren zu ihrer Herstellung
US3069322A (en) * 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf
US4163108A (en) * 1967-02-16 1979-07-31 Lever Brothers Company Prostaglandins
GB1274453A (en) * 1968-08-02 1972-05-17 American Home Prod Bronchodilatory compositions and nebulizers containing them
GT196914163A (es) * 1968-08-29 1971-01-26 Composicion y proceso
BR6915068D0 (pt) * 1969-03-14 1973-05-24 Upjohn Co Processo de producao de derivados racemicos de prostaglandina
US3852316A (en) * 1970-03-09 1974-12-03 Upjohn Co Prostaglandin f2 {62 {0 analogs
US3725469A (en) * 1970-03-23 1973-04-03 Upjohn Co Prostanoic acid derivatives
DE2117188C3 (de) * 1970-04-15 1975-02-06 Ono Pharmaceutical Co., Ltd., Osaka (Japan) Prostaglandin-A tief 2-decylester, Verfahren zu seiner Herstellung sowie diesen enthaltende pharmazeutische Zubereitungen
US3657327A (en) * 1970-06-01 1972-04-18 Upjohn Co Prostaglandin salts of tris(hydroxymethyl)aminomethane
US3903131A (en) * 1971-04-12 1975-09-02 Upjohn Co 16 and 16,16-dimethyl PGE{HD 2{B
US3880912A (en) * 1971-07-02 1975-04-29 Upjohn Co Composition and process
US3928425A (en) * 1971-07-02 1975-12-23 Upjohn Co 11{62 ,15{62 -PGE{HD 2{B ,15{62 -PGF{HD 2{301 {B , and 15{62 -PGF{HD 2{331 {B , 15-acetates methyl esters
US3919293A (en) * 1971-07-02 1975-11-11 Upjohn Co PGE{HD 2{B , 15-acetate, methyl ester
US3922293A (en) * 1971-12-30 1975-11-25 Upjohn Co Prostaglandin F-type 9-monoacylates
US4001306A (en) * 1971-12-30 1977-01-04 The Upjohn Company Prostaglandin F.sub.α 15-monoacrylates
BE793535A (fr) * 1971-12-30 1973-06-29 Upjohn Co Nouveaux derives de prostaglandines et leur procede de preparation
US4130721A (en) * 1972-07-24 1978-12-19 The Upjohn Company 11-Deoxy PGE2 compounds
US3965148A (en) * 1972-08-16 1976-06-22 Ciba-Geigy Corporation Perfluoroalkyl alcohols
US3987067A (en) * 1974-01-08 1976-10-19 The Upjohn Company Substituted aromatic esters of PGF2.sub.α
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
NL7605381A (nl) * 1975-05-26 1976-11-30 Schering Ag Werkwijze voor het bereiden van prostaanderi- vaten en werkwijze voor het bereiden van een geneesmiddel met prostaglandinewerking.
US4005133A (en) * 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
AU510190B2 (en) * 1976-08-14 1980-06-12 Carlson, Lars A Prostaglandin method
US4338325A (en) * 1977-07-28 1982-07-06 The Upjohn Company PGI2 Pharmacologically acceptable salts
US4564637A (en) * 1981-08-19 1986-01-14 Schachar Ronald A Method for maintaining corneal shape after radial keratotomy
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
US4739078A (en) * 1984-02-17 1988-04-19 The Upjohn Company Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
DE3420493A1 (de) * 1984-06-01 1985-12-05 Ruhrchemie Ag, 4200 Oberhausen Quartaere ammoniumsalze sulfonierter triarylphosphine
WO1990004046A1 (en) * 1988-10-12 1990-04-19 Murray W Bruce Corrosion inhibition of sodium and calcium chloride
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
US5139491A (en) * 1990-12-06 1992-08-18 Allergan, Inc. 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
US5380760A (en) * 1993-11-19 1995-01-10 Minnesota Mining And Manufacturing Company Transdermal prostaglandin composition
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6068012A (en) 1998-12-29 2000-05-30 Ashland, Inc. Performance-based control system
EP1159266B1 (en) 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2006052864A2 (en) 2004-11-04 2006-05-18 Nexmed (Holdings), Inc. Facilitation of central nervous system sexual responses
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
NZ594310A (en) 2009-02-20 2014-02-28 To Bbb Holding B V Glutathione-based drug delivery system
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2023146984A1 (en) * 2022-01-26 2023-08-03 Amarin Pharmaceuticals Ireland Limited Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH91825A (de) * 1920-08-06 1921-12-01 Deumelandt Otto Bieruntersatz mit Zählvorrichtung.
US3069322A (en) * 1958-05-28 1962-12-18 Bergstrom Sune Pge and pgf

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003441A1 (en) * 1984-02-13 1985-08-15 Lars Hellgren An erection and fertility promoting agent, a method for producing the same, and the use thereof in the production of erection and fertility promoting compositions

Also Published As

Publication number Publication date
DE1643740B1 (de) 1972-05-31
US3069322A (en) 1962-12-18
DK130067C (xx) 1975-05-26
SE305870B (xx) 1968-11-11
GB851827A (en) 1960-10-19
SE337887B (xx) 1971-08-23
US3795697A (en) 1974-03-05
GB1040545A (en) 1966-09-01
DE1643738B1 (de) 1972-06-29
DE1643740C2 (xx) 1973-01-04
DK130067B (da) 1974-12-16
US3691216A (en) 1972-09-12
SE323473B (xx) 1970-05-04
DK126106B (da) 1973-06-12
DE1160981B (de) 1964-01-09
US3852337A (en) 1974-12-03
SE305868B (xx) 1968-11-11
DE1443474A1 (de) 1968-11-14
US3598858A (en) 1971-08-10
GB1040544A (en) 1966-09-01
SE305869B (xx) 1968-11-11
SE339531B (xx) 1971-10-11
US3706789A (en) 1972-12-19

Similar Documents

Publication Publication Date Title
DK130067C (xx)
AT221043B (xx)
AT213908B (xx)
AT213558B (xx)
FR519M (xx)
AT219815B (xx)
AT219868B (xx)
BE438342A (xx)
BE557464A (xx)
BE555601A (xx)
BE548156A (xx)
BE543812A (xx)
BE543487A (xx)
BE539571A (xx)
BE538749A (xx)
BE531097A (xx)
BE529624A (xx)
BE518340A (xx)
BE508172A (xx)
BE455804A (xx)
BE563346A (xx)
BE560415A (xx)
BE374830A (xx)
BE558579A (xx)
NL105178C (xx)